Monitoring of circulating tumor cells during systemic therapy allows distinguishing breast cancer patients at risk for relapse

被引：0
|
作者：
Pachmann, K.
Camara, O.
Lobodasch, K.
Clement, J.
Dengler, R.
Hoeffken, K.
机构：
[1] Clin Internal Med II, Jena, Germany
[2] Friedrich Schiller Univ, Jena, Germany
[3] DRK Krankenhaus Chemnitz Rabenstein, Chemnitz, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11006
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse
    Pachmann, Katharina
    Camara, Oumar
    Kavallaris, Andreas
    Krauspe, Sabine
    Malarski, Nele
    Gajda, Mieczyslaw
    Kroll, Torsten
    Joerke, Cornelia
    Hammer, Ulrike
    Altendorf-Hofmann, Annelore
    Rabenstein, Carola
    Pachmann, Ulrich
    Runnebaum, Ingo
    Hoeffken, Klaus
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1208 - 1215
  • [2] Circulating epithelial tumor cells a new tool for therapy monitoring in breast cancer: a more than tenfold increase in numbers during systemic therapy is highly predictive of relapse
    Pachmann, K.
    Camara, O.
    Cavallaris, A.
    Krauspe, S.
    Malarski, N.
    Gajda, M.
    Kroll, T.
    Hoeffken, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S26 - S27
  • [3] The initial response of circulating epithelial tumor cells (CETC) during primary systemic therapy of breast cancer is predictive for early relapse
    Pachmann, K.
    Camara, O.
    Gajda, M.
    Untch, M.
    Hoeffken, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 136 - 136
  • [4] The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
    Camara, O.
    Rengsberger, M.
    Egbe, A.
    Koch, A.
    Gajda, M.
    Hammer, U.
    Jorke, C.
    Rabenstein, C.
    Untch, M.
    Pachmann, K.
    ANNALS OF ONCOLOGY, 2007, 18 (09) : 1484 - 1492
  • [5] Molecular characterization of circulating tumor cells allows stratifying for prognosis in breast cancer patients undergoing neoadjuvant therapy
    Koenig, Lisa
    Hoffmann, Oliver
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    CANCER RESEARCH, 2015, 75
  • [6] The Value of Monitoring the Behavior of Circulating Tumor Cells at the End of Endocrine Therapy in Breast Cancer Patients
    Pachmann, Katharina
    Schuster, Stefan
    CANCERS, 2018, 10 (11):
  • [7] Circulating Tumor Cells during Radiotherapy in Breast Cancer Patients
    Boelke, E.
    Bojar, H.
    Prisack, H.
    Matuschek, C.
    Budach, W.
    Gripp, S.
    Peiper, M.
    Dogan, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S201 - S201
  • [8] Circulating Tumor Cells in Patients with Breast Cancer: Monitoring Chemotherapy Success
    Usiakova, Zuzana
    Mikulova, Veronika
    Pinterova, Daniela
    Brychta, Milan
    Valchar, Josef
    Kubecova, Martina
    Tesarova, Petra
    Bobek, Vladimir
    Kolostova, Katarina
    IN VIVO, 2014, 28 (04): : 605 - 614
  • [9] Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
    Gwark, S-C
    Kim, J.
    Kim, Y. H.
    Kim, M. S.
    Park, J. Y.
    Lee, S. B.
    Sohn, G.
    Chung, I. Y.
    Ko, B. S.
    Kim, H. J.
    Lee, J. W.
    Son, B. H.
    Ahn, S. H.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
    Alemzadeh, Effat
    Allahqoli, Leila
    Dehghan, Hamideh
    Mazidimoradi, Afrooz
    Ghasempour, Alireza
    Salehiniya, Hamid
    ONCOLOGY RESEARCH, 2023, 31 (05) : 667 - 675
12345